Leading BioSolutions Platform

Proforma UPL Income Statement: FY2019 Particulars Reported Financials FY 2019 INR crore Arysta* Arysta Acquisition Acquisition Related PPA** Proforma Legacy UPL Proforma FY2019 % INR crore INR crore INR crore INR crore FY 2018 Change % INR crore % % Total Revenue from operation 21,837 100% 1,968 19,869 100% 17,378 100% 14% Variable Cost Contribution 13,263 1,143 442 11,678 10,204 & 14% 8,574 39% 825 (442) 8,191 41% 7,174 41% 14% Fixed Overheads 4,461 C& 408 4,053 3,658 11% EBITDA 4,113 19% 417 (442) 4,138 21% 3,516 20% 18% Other Income (60) (13) (47) 403 -112% Amortization/ Depreciation 969 4X 120 102 747 ( 675 11% Finance Cost 963 14 131 818 783 4% PBT 2,121 10% 270 (131) (544) 2,526 13% 2,461 14% 3% Tax 165 108 (163) 220 275 -20% PAT 1,956 9% 162 (131) (381) 2,306 12% 2,186 13% 5% Income from Associate Co. and JV 14 1 13 (93) -114% Profit After Tax & Associate Income 1,970 9% 163 (131) (381) 2,319 12% 2,093 12% 11% Exceptional Cost Minority Interest 451 72 37 (5) 336 78 61 16 10 63 8 24% 100% Profit After Tax, Asso. Inc. & 1,447 7% 131 (528) (381) 2,225 11% 2,022 12% 10% Exceptionals AUDITED * Arysta figures are for 2 months (February & March 2019) ** PPA (Purchase Price Allocation) 52

View entire presentation